Proteins, Cyclic AMP-Dependent Protein Kinases, Cyclic AMP, Protein Isoforms, Chemical Activation, Cyclic AMP Receptor Protein, Protein Kinases, Catalytic Domain
Our laboratory studies intracellular signaling associated with second messenger cAMP. We apply multidisciplinary approaches, coupling biochemistry, biophysics and cell biology with pharmacology and chemical biology, to understand the structure and function of exchange proteins directly activated by cAMP (EPAC). Our goals are to unravel the signaling intricacies of EPAC proteins and to design pathway specific probes for these important signaling molecules so that their functions can be pharmaceutically exploited and modulated for the treatment of human diseases. Our laboratory has developed first-in-class EPAC selective inhibitors and EPAC knockout mouse models to study the physiological functions and diseases relevance of this family of important signaling molecules. Recently, we have identified a potential use of EPAC inhibitors in the prevention and treatment of fatal rickettsioses. Currently, we are actively engaged in developing second generation isoform specific EPAC inhibitors and agonists and in exploring their potential uses in various human diseases including cancer, diabetes, chronic pain and infections.
Publications/Creative Works
Click here to search for this faculty member's publications on PubMed.
Affiliations
Training Grants
Houston Area Molecular Biophysics Training Program
Research Consortia
GCC Cluster NanoX
Gulf Coast Consortium for Translational Pain Research
Training Grants
Training Interdisciplinary Pharmacological Scientists
Important Disclaimer: The responsibility for the accuracy of the information contained on these pages lies with the authors and user providing such information.